Platinum-resistant Ovarian Cancer Terminated Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04729608Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian CancerTreatment